These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19243386)

  • 1. Glypican 3-expressing gastric carcinoma: distinct subgroup unifying hepatoid, clear-cell, and alpha-fetoprotein-producing gastric carcinomas.
    Ushiku T; Uozaki H; Shinozaki A; Ota S; Matsuzaka K; Nomura S; Kaminishi M; Aburatani H; Kodama T; Fukayama M
    Cancer Sci; 2009 Apr; 100(4):626-32. PubMed ID: 19243386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma.
    Ushiku T; Shinozaki A; Shibahara J; Iwasaki Y; Tateishi Y; Funata N; Fukayama M
    Am J Surg Pathol; 2010 Apr; 34(4):533-40. PubMed ID: 20182341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular oncofetal protein, glypican 3 is a sensitive marker for alpha-fetoprotein-producing gastric carcinoma.
    Hishinuma M; Ohashi KI; Yamauchi N; Kashima T; Uozaki H; Ota S; Kodama T; Aburatani H; Fukayama M
    Histopathology; 2006 Nov; 49(5):479-86. PubMed ID: 17064293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary.
    Esheba GE; Pate LL; Longacre TA
    Am J Surg Pathol; 2008 Apr; 32(4):600-7. PubMed ID: 18277882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological study of five cases.
    Murakami T; Yao T; Yatagai N; Yamashiro Y; Saito T; Sakamoto N; Nagahara A
    Histopathology; 2020 Jan; 76(2):325-332. PubMed ID: 31429980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. α-Fetoprotein-producing gastric carcinoma and combined hepatocellular and cholangiocarcinoma show similar morphology but different histogenesis with respect to SALL4 expression.
    Ikeda H; Sato Y; Yoneda N; Harada K; Sasaki M; Kitamura S; Sudo Y; Ooi A; Nakanuma Y
    Hum Pathol; 2012 Nov; 43(11):1955-63. PubMed ID: 22516245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different characteristics of hepatoid and non-hepatoid alpha-fetoprotein-producing gastric carcinomas: an experimental study using xenografted tumors.
    Aizawa K; Motoyama T; Suzuki S; Tanaka N; Yabusaki H; Tanaka S; Muto I; Tanaka O; Hatakeyama K
    Int J Cancer; 1994 Aug; 58(3):430-5. PubMed ID: 7519587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic and immunohistochemical characteristics of gastric adenocarcinoma with enteroblastic differentiation: a study of 29 cases.
    Murakami T; Yao T; Mitomi H; Morimoto T; Ueyama H; Matsumoto K; Saito T; Osada T; Nagahara A; Watanabe S
    Gastric Cancer; 2016 Apr; 19(2):498-507. PubMed ID: 25893262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncofetal protein glypican-3 in testicular germ-cell tumor.
    Ota S; Hishinuma M; Yamauchi N; Goto A; Morikawa T; Fujimura T; Kitamura T; Kodama T; Aburatani H; Fukayama M
    Virchows Arch; 2006 Sep; 449(3):308-14. PubMed ID: 16896894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-fetoprotein-producing gastric carcinoma with enteroblastic differentiation.
    Matsunou H; Konishi F; Jalal RE; Yamamichi N; Mukawa A
    Cancer; 1994 Feb; 73(3):534-40. PubMed ID: 7507794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of miR-4510 as a metastasis suppressor of gastric cancer through regulation of tumor microenvironment via targeting GPC3.
    Ma HF; Shu P; Shi XH; Wang M; Jiang MF
    Clin Exp Metastasis; 2022 Apr; 39(2):363-374. PubMed ID: 35050429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-fetoprotein-producing gastric carcinoma presenting focal hepatoid differentiation in metastatic lymph nodes.
    Kang GH; Kim YI
    Virchows Arch; 1998 Jan; 432(1):85-7. PubMed ID: 9463592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Both the serum AFP test and AFP/GPC3/SALL4 immunohistochemistry are beneficial for predicting the prognosis of gastric adenocarcinoma.
    Wang B; Xie Y; Zheng L; Zheng X; Gao J; Liu X; Yuan Y; Li Z; Lu N; Xue L
    BMC Gastroenterol; 2021 Oct; 21(1):408. PubMed ID: 34706681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Two cases of gastric cancer expressing Glypican 3, but producing AFP with different lectin affinity].
    Oishi C; Baba T; Kubota Y; Shimotsuma Y; Kitamura K; Honma T; Ikegami A; Inokuchi M; Umeda T; Yoshida H; Imawari M
    Nihon Shokakibyo Gakkai Zasshi; 2009 Jun; 106(6):805-12. PubMed ID: 19498312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Glypican-3 as a potential metastasis suppressor gene in gastric cancer.
    Han S; Ma X; Zhao Y; Zhao H; Batista A; Zhou S; Zhou X; Yang Y; Wang T; Bi J; Xia Z; Bai Z; Garkavtsev I; Zhang Z
    Oncotarget; 2016 Jul; 7(28):44406-44416. PubMed ID: 27259271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glypican-3: a novel diagnostic marker for hepatocellular carcinoma and more.
    Kandil DH; Cooper K
    Adv Anat Pathol; 2009 Mar; 16(2):125-9. PubMed ID: 19550373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment and biological characterization of a novel cell line derived from hepatoid adenocarcinoma originated at the ampulla of Vater.
    Takahashi N; Aoyama F; Hiyoshi M; Kataoka H; Sawaguchi A
    Int J Oncol; 2014 Apr; 44(4):1139-45. PubMed ID: 24481592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma.
    Yamauchi N; Watanabe A; Hishinuma M; Ohashi K; Midorikawa Y; Morishita Y; Niki T; Shibahara J; Mori M; Makuuchi M; Hippo Y; Kodama T; Iwanari H; Aburatani H; Fukayama M
    Mod Pathol; 2005 Dec; 18(12):1591-8. PubMed ID: 15920546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of RNA-binding protein LIN28 in classic gastric hepatoid carcinomas, gastric fetal type gastrointestinal adenocarcinomas, and hepatocellular carcinomas: An immunohistochemical study with comparison to SALL4, alpha-fetoprotein, glypican-3, and Hep Par1.
    Zhao M; Sun L; Lai JZ; Shi H; Mei K; He X; Jin X; Lai J; Cao D
    Pathol Res Pract; 2018 Oct; 214(10):1707-1712. PubMed ID: 30196987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HER2 is frequently overexpressed in hepatoid adenocarcinoma and gastric carcinoma with enteroblastic differentiation: a comparison of 35 cases to 334 gastric carcinomas of other histological types.
    Fujimoto M; Matsuzaki I; Nishino M; Iwahashi Y; Warigaya K; Kojima F; Ono K; Murata SI
    J Clin Pathol; 2018 Jul; 71(7):600-607. PubMed ID: 29305518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.